Agios to Webcast Conference Call of Fourth Quarter and Year End 2022 Financial Results on Feb. 23, 2023
02 February 2023 - 11:00PM
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field
of cellular metabolism pioneering therapies for rare diseases,
today announced the company will host a conference call and live
webcast on Thursday, February 23, 2023, at 8:00 a.m. ET to report
its fourth quarter and year end 2022 financial results and other
business highlights.
A live webcast can be accessed under “Events &
Presentations” in the Investors section of the company’s website
at www.agios.com. The webcast will be archived and made
available for replay on the company’s website beginning
approximately two hours after the event.
About AgiosAgios is a biopharmaceutical company
that is fueled by connections. The Agios team cultivates strong
bonds with patient communities, healthcare professionals, partners
and colleagues to discover, develop and deliver therapies for rare
diseases. In the U.S., Agios markets a first-in-class pyruvate
kinase (PK) activator for adults with PK deficiency, the first
disease-modifying therapy for this rare, lifelong, debilitating
hemolytic anemia. Building on the company's leadership in the field
of cellular metabolism, Agios is advancing a robust clinical
pipeline of investigational medicines with programs in alpha- and
beta-thalassemia, sickle cell disease, pediatric PK deficiency and
MDS-associated anemia. In addition to its clinical pipeline, Agios
has multiple investigational therapies in preclinical development
and deep scientific expertise in classical hematology. For more
information, please visit the company’s website at
www.agios.com.
Contacts
Investors:Adam Bero, Ph.D.Kendall Investor
Relationsabero@kendallir.com
Media:Jessica RennekampSenior Director,
Corporate CommunicationsJessica.Rennekamp@agios.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Apr 2023 to Apr 2024